Publisher
source

University of Florida

Just Landed

Postdoctoral Associate in Genetically Engineered Probiotic Therapeutics for Diabetes and Metabolic Disorders University of Florida in United States

Degree Level

Postdoc

Field of study

Pharmacology

Funding

Salary is commensurate with experience. No stipend or tuition details are provided.

Deadline

Nov 6, 2026

Country flag

Country

United States

University

University of Florida

Social connections

How do I apply for this?

Sign in for free to reveal details, requirements, and source links.

Apply for this position

Keywords

Pharmacology
Immunology
Molecular Biology
Microbiology
Biomedical Engineering
Biology
Medical Science
Pharmacy
Pharmaceutical Chemistry
Insulin
Post Doc

Suggested positions

About this position

Postdoctoral Associate at the University of Florida in Gainesville, Florida, United States.

This postdoctoral opening focuses on genetically engineered probiotic therapeutics for the treatment of diabetes and metabolic disorders. The successful candidate will lead preclinical development work including pharmacokinetic and bioavailability studies, toxicology, dose-response and efficacy experiments in rodent models, engineering and characterization of probiotic strains, bioanalytical assay development, data analysis, and preparation of manuscripts, grant applications, and regulatory documentation.

Applicants should hold a Ph.D. in Pharmacology, Pharmaceutical Sciences, Biomedical Engineering, Microbiology, Molecular Biology, Immunology, or a related field. The role calls for strong written and verbal communication skills, independence, and ownership of projects. Desired experience includes in vivo pharmacology, diabetes mouse models, PK/PD analysis, microbiome therapeutics, and peptide biologics. Preference is given to candidates with 2–5 years of hands-on rodent model experience, a strong publication record in metabolic disease, microbiome therapeutics, or drug delivery, and interdisciplinary collaboration experience spanning microbiology, pharmacology, toxicology, and bioengineering.

Application materials include a cover letter, research statement, CV, and three professional references. The posting notes that letters should be addressed to Qiuhong Li, PhD, Associate Professor of Ophthalmology. A health assessment for animal contact is required.

Deadline: 2026-11-06.

Funding details

Salary is commensurate with experience. No stipend or tuition details are provided.

What's required

Ph.D. in Pharmacology, Pharmaceutical Sciences, Biomedical Engineering, Microbiology, Molecular Biology, Immunology, or a related field. Candidates should have excellent written and verbal communication skills, be dynamic and self-motivated, and be able to take ownership of projects. Required expertise includes in vivo pharmacology, diabetes mouse models, PK/PD analysis, microbiome therapeutics, and peptide biologics. Preferred qualifications include 2–5 years of hands-on experience with rodent models of diabetes and metabolic disease, a strong publication record in metabolic disease, microbiome therapeutics, or drug delivery, and experience collaborating across microbiology, pharmacology, toxicology, and bioengineering.

How to apply

Submit the application through the University of Florida jobs portal. Upload a cover letter, research statement, CV, and three professional references or a reference list if letters are unavailable. Letters should be addressed to Qiuhong Li, PhD, Associate Professor of Ophthalmology.

More information can be found here

Ask ApplyKite AI

Start chatting
Can you summarize this position?
What qualifications are required for this position?
How should I prepare my application?